Literature DB >> 22130008

Functions of OATP1A and 1B transporters in vivo: insights from mouse models.

Dilek Iusuf1, Evita van de Steeg, Alfred H Schinkel.   

Abstract

Organic anion-transporting polypeptides (OATPs) are a superfamily of uptake transporters that mediate the cellular uptake of a broad range of endogenous and exogenous compounds. Of these OATP transporters, members of the 1A and 1B subfamilies have broad substrate specificities. Because they are mainly expressed in liver, kidney and small intestine, OATP1A and 1B transporters can have a major impact on the pharmacokinetics of many drugs. To study their role in physiology and drug disposition, several mouse models lacking functional expression of one or more OATPs have been generated. This review discusses recent findings for these models that have led to new insights into the impact of OATP1A and 1B transporters on pharmacokinetics and toxicokinetics, and on bilirubin detoxification and bile acid handling in normal liver physiology.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130008     DOI: 10.1016/j.tips.2011.10.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  30 in total

1.  Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Authors:  Charles S Venuto; Marianthi Markatou; Yvonne Woolwine-Cunningham; Rosemary Furlage; Andrew J Ocque; Robin DiFrancesco; Emily O Dumas; Paul K Wallace; Gene D Morse; Andrew H Talal
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.

Authors:  Natacha Lenuzza; Xavier Duval; Grégory Nicolas; Etienne Thévenot; Sylvie Job; Orianne Videau; Céline Narjoz; Marie-Anne Loriot; Philippe Beaune; Laurent Becquemont; France Mentré; Christian Funck-Brentano; Loubna Alavoine; Philippe Arnaud; Marcel Delaforge; Henri Bénech
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-03       Impact factor: 2.441

3.  Oatp1a1 requires PDZK1 to traffic to the plasma membrane by selective recruitment of microtubule-based motor proteins.

Authors:  Wen-Jun Wang; John W Murray; Allan W Wolkoff
Journal:  Drug Metab Dispos       Date:  2013-10-10       Impact factor: 3.922

4.  Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS.

Authors:  Bo Gao; Stephan R Vavricka; Peter J Meier; Bruno Stieger
Journal:  Pflugers Arch       Date:  2014-08-19       Impact factor: 3.657

5.  Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

Authors:  Annemieke J M Nieuweboer; Shuiying Hu; Chunshan Gui; Bruno Hagenbuch; Inge M Ghobadi Moghaddam-Helmantel; Alice A Gibson; Peter de Bruijn; Ron H J Mathijssen; Alex Sparreboom
Journal:  Cancer Res       Date:  2014-04-22       Impact factor: 12.701

6.  Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.

Authors:  Michelle Kim; Perri Deacon; Rommel G Tirona; Richard B Kim; Christopher L Pin; Henriette E Meyer Zu Schwabedissen; Rennian Wang; Ute I Schwarz
Journal:  Histochem Cell Biol       Date:  2017-05-10       Impact factor: 4.304

7.  OATP1B1 polymorphism as a determinant of erythromycin disposition.

Authors:  C S Lancaster; G H Bruun; C J Peer; T S Mikkelsen; T J Corydon; A A Gibson; S Hu; S J Orwick; R H J Mathijssen; W D Figg; S D Baker; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2012-09-19       Impact factor: 6.875

Review 8.  New insights in bilirubin metabolism and their clinical implications.

Authors:  Eva Sticova; Milan Jirsa
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 9.  Bile Acids: A Communication Channel in the Gut-Brain Axis.

Authors:  Vera F Monteiro-Cardoso; Maria Corlianò; Roshni R Singaraja
Journal:  Neuromolecular Med       Date:  2020-10-21       Impact factor: 3.843

10.  Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.

Authors:  Eric I Zimmerman; Shuiying Hu; Justin L Roberts; Alice A Gibson; Shelley J Orwick; Lie Li; Alex Sparreboom; Sharyn D Baker
Journal:  Clin Cancer Res       Date:  2013-01-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.